https://www.selleckchem.com/products/blu-945.html
Finally, we discuss possible future challenges, improvements, and perspectives. The aim of this study was to examine the relationship between chronic obstructive pulmonary disease (COPD) and outcomes after transcatheter mitral valve repair (TMVr) for severe secondary mitral regurgitation. TMVr with the MitraClip improves clinical and health-status outcomes in patients with heart failure and severe (3+ to 4+) secondary mitral regurgitation. Whether these benefits are modified by COPD is unknown. COAPT (Cardiovascular Outcomes Assessment
Like
Comment
Share